Core One Labs Inc
CNSX:COOL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Tungsten and Hightech Materials Co Ltd
SZSE:000657
|
CN |
Core One Labs Inc
Long-Term Debt
Core One Labs Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Core One Labs Inc
CNSX:COOL
|
Long-Term Debt
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Long-Term Debt
$20.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Long-Term Debt
CA$242.3m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
52%
|
|
|
Cronos Group Inc
TSX:CRON
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Long-Term Debt
$40.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Long-Term Debt
CA$57.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
|
Core One Labs Inc
Glance View
Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-08-17. The firm is focused on advancing psychedelic medicines to market through delivery systems and psychedelic assisted psychotherapy and active pharmaceutical ingredients (API) grade psilocybin manufacturing. Core One has developed its technology, thin film oral strip, which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining bioavailability. The firm also intends to develop and apply the technology to psychedelic compounds, such as psilocybin. Core One produce current Good Manufacturing Practice (cGMP) API grade psilocybin for use by pharmaceutical companies, API manufacturers and organizations conducting clinical trials, providing access to organizations. Core One also holds an interest in medical clinics, which maintain a combined database of approximately 275,000 patients.
See Also
What is Core One Labs Inc's Long-Term Debt?
Long-Term Debt
0
CAD
Based on the financial report for Dec 31, 2023, Core One Labs Inc's Long-Term Debt amounts to 0 CAD.